Kylee Maclachlan

49PUBLICATIONS
234CO-AUTHORS
Predictive and prognostic markersHaematological tumoursMedical bacteriologyGene expression (incl. microarray and other genome-wide approaches)Medical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (49)

|Sep 24, 2026
Dynamic risk stratification in smoldering multiple myeloma: Integrating evolving biomarkers with the 2/20/20 Model.

|Jul 29, 2026
Robust CD4+ CAR T cell expansion is associated with non-ICANS neurotoxicities after ciltacabtagene autoleucel in patients with multiple myeloma.

|Jul 20, 2026
Lenalidomide-Related Diarrhea in Patients with Multiple Myeloma Is Associated with Gut Microbiota Dysbiosis and Disruption of the Bile Acid Pool.

|Jun 12, 2026
Genomic Features Do Not Account for Differences in Multiple Myeloma Risk by Ancestry.

|Apr 20, 2026
Whole-genome sequencing of cell-free DNA for assessment of minimal residual disease in high-risk smoldering multiple myeloma.

|Apr 12, 2026
Functionally high-risk disease is associated with poor outcomes after late-line CAR T-cell therapy for multiple myeloma.

Hamza Hashmi, Tara Sebastian, Sridevi Rajeeve

Pageof 9

Frequent Collaborators

36 joint publications

Malin L Hultcrantz

28 joint publications

Urvi Shah

26 joint publications

Neha Korde

25 joint publications

Saad Z Usmani